ABN AMRO Funds - Aia.com.hk
ABN AMRO Funds - Aia.com.hk
ABN AMRO Funds - Aia.com.hk
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Statement of investments -<br />
Global Property Equity Fund 30-04-2008<br />
Statement of investments -<br />
Health Care Fund 30-04-2008<br />
Number<br />
Transferable securities<br />
and money market<br />
instruments admitted to<br />
an official stock exchange<br />
listing<br />
RIGHTS<br />
Finland<br />
49,500 Technopolis OYJ - rights -<br />
20.05.2008<br />
Fair<br />
value<br />
x USD<br />
% of<br />
Total<br />
Net<br />
Assets<br />
0 0.00<br />
0 0.00<br />
TOTAL RIGHTS 0 0.00<br />
TOTAL TRANSFERABLE SECURITIES AND<br />
MONEY MARKET INSTRUMENTS ADMITTED TO<br />
AN OFFICIAL STOCK EXCHANGE LISTING<br />
111,389,751 98.41<br />
TOTAL INVESTMENTS IN SECURITIES 111,389,751 98.41<br />
OTHER ASSETS LESS LIABILITIES 1,803,809 1.59<br />
TOTAL NET ASSETS 113,193,560 100.00<br />
Number<br />
Transferable securities<br />
and money market<br />
instruments admitted to<br />
an official stock exchange<br />
listing<br />
Fair<br />
value<br />
x EUR<br />
% of<br />
Total<br />
Net<br />
Assets<br />
SHARES<br />
Australia<br />
48,329 CSL 1,149,613 1.14<br />
1,149,613 1.14<br />
Denmark<br />
51,837 Novo Nordisk - B - 2,285,261 2.27<br />
2,285,261 2.27<br />
Germany<br />
41,319 Bayer 2,264,281 2.25<br />
9,021 Stada Arzneimittel 393,406 0.39<br />
2,657,687 2.64<br />
Israel<br />
39,737 Teva Pharmaceutical Industries -<br />
Sp. ADR -<br />
1,193,973 1.19<br />
1,193,973 1.19<br />
Netherlands<br />
39,071 Qiagen 563,013 0.56<br />
563,013 0.56<br />
Norway<br />
210,728 Pronova BioPharma 466,180 0.46<br />
466,180 0.46<br />
Spain<br />
36,873 Laboratorios Almirall 496,311 0.49<br />
496,311 0.49<br />
Switzerland<br />
21,254 Alcon 2,156,935 2.14<br />
200,724 Novartis 6,523,326 6.48<br />
57,287 Roche Holding 6,104,624 6.06<br />
14,784,885 14.68<br />
United Kingdom<br />
205,829 GlaxoSmithKline 2,935,199 2.91<br />
65,154 Hikma Pharmaceuticals 389,551 0.39<br />
61,322 Shire 730,549 0.73<br />
186,509 Smith & Nephew 1,554,055 1.54<br />
5,609,354 5.57<br />
United States<br />
169,379 Abbott Laboratories 5,738,803 5.70<br />
94,547 Aetna 2,647,729 2.63<br />
73,488 Baxter International 2,941,597 2.92<br />
29,890 Becton Dickinson & Co 1,716,338 1.70<br />
49,935 BioMimetic Therapeutics 314,960 0.31<br />
255,688 Bristol-Myers Squibb 3,608,109 3.58<br />
74,027 Celgene 2,954,613 2.93<br />
32,335 Cigna 887,037 0.88<br />
27,210 CR Bard 1,645,813 1.63<br />
53,460 Express Scripts 2,404,309 2.39<br />
57,876 Genentech 2,535,258 2.52<br />
42,007 Genzyme 1,898,126 1.88<br />
139,615 Gilead Sciences 4,641,578 4.61<br />
50,782 Inverness Medical Innovations 1,206,843 1.20<br />
227,105 Johnson & Johnson 9,786,418 9.72<br />
39,662 McKesson 1,327,756 1.32<br />
83,232 Medco Health Solutions 2,648,412 2.63<br />
97,532 Medtronic 3,049,559 3.03<br />
193,805 Merck & Co 4,735,270 4.70<br />
216,386 Pfizer 2,794,992 2.78<br />
28,556 Pharmaceutical Product<br />
759,708 0.75<br />
Development<br />
70,009 Resmed 1,938,974 1.93<br />
45,465 St Jude Medical 1,278,475 1.27<br />
43,974 Thermo Electron 1,634,514 1.62<br />
The ac<strong>com</strong>panying notes to the financial statements form an integral part of these financial statements.<br />
42
Change language